RSHU.F Stock Overview
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Respiri Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.01 |
| 52 Week High | AU$0.06 |
| 52 Week Low | AU$0.006 |
| Beta | -0.033 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -92.81% |
| 5 Year Change | -81.13% |
| Change since IPO | -47.37% |
Recent News & Updates
Recent updates
Shareholder Returns
| RSHU.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -4.1% | -3.7% |
| 1Y | n/a | -2.2% | 20.5% |
Return vs Industry: Insufficient data to determine how RSHU.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how RSHU.F performed against the US Market.
Price Volatility
| RSHU.F volatility | |
|---|---|
| RSHU.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: RSHU.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine RSHU.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Marjan Mikel | respiri.co |
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. The company develops, produces, and sells mobile health applications. Its products include wheezo, an electronic wheeze detection tool to detect wheeze in children; respiri mobile application; and Respiri health portal.
Respiri Limited Fundamentals Summary
| RSHU.F fundamental statistics | |
|---|---|
| Market cap | US$20.86m |
| Earnings (TTM) | -US$4.19m |
| Revenue (TTM) | US$518.10k |
40.3x
P/S Ratio-5.0x
P/E RatioIs RSHU.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RSHU.F income statement (TTM) | |
|---|---|
| Revenue | AU$789.74k |
| Cost of Revenue | AU$23.74k |
| Gross Profit | AU$766.00k |
| Other Expenses | AU$7.15m |
| Earnings | -AU$6.39m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.006 |
| Gross Margin | 96.99% |
| Net Profit Margin | -808.52% |
| Debt/Equity Ratio | 0% |
How did RSHU.F perform over the long term?
See historical performance and comparison